Answers are grounded in this paper and cite their sources.
Pancreatic ductal adenocarcinoma upregulates CD73, potentially contributing to immune surveillance evasion. Combining oleclumab (CD73 inhibitor) and durvalumab with chemotherapy may identify an effective treatment option.
No takes yet. Share an insight, caveat, or question.
Coveler et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: